There has been increasing interest in the association between neural tube defects, dolutegravir, and integrase inhibitors as a class since 4 cases were reported in 2018.
Celeste Caulder, PharmD
Advertisement
Articles by Celeste Caulder, PharmD
Advertisement
Latest Updated Articles
- Antiretroviral Safety in Pregnancy: Focus on Dolutegravir, Integrase Inhibitors, and Neural Tube Defects
Published: August 13th 2019 | Updated:
Advertisement
Advertisement
Trending on Contagion Live
1
Once-Weekly Oral Islatravir Plus Lenacapavir Maintains HIV Suppression Through 48 Weeks
2
CDC Awards Grant to Study Neonatal Hepatitis B Vaccination Outcomes in Guinea-Bissau
3
Working in a Hot Zone: Building Trust With Local Communities, Addressing Gaps In Preparedness
4
WHO Certifies Countries as Malaria Free in Face of Persistent Antimalarial Drug Resistance
5